1. Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. American Journal of Obstetrics and Gynecology 2002;186(6):1111‐8.
2. Crowther CA, Hiller JE, Doyle LW, Haslam RR for the Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003;290(20):2669‐76.
3. Marret S, Marpeau L, Zupan‐Simunek V, Eurin D, Lévêque C, Hellot MF, et al. Magnesium sulfate given before very‐preterm birth to protect infant brain: the randomized, controlled PREMAG trial. BJOG: an international journal of obstetrics and gynaecology2007; Vol. 114, issue 3:310‐8.
4. Magpie Trial Follow Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre‐eclampsia. Outcome for children at 18 months. BJOG: an international journal of obstetrics and gynaecology 2007;114(3):289‐99.
5. Rouse D, Hirtz D, Thom E, Varner M, Alexander J, Spong C, Mercer B, Iams J, Wapner R, Sorokin Y, Harper M, Thorp J, Ramin S, Malone F, Carpenter M, Miodovnik A, Moawad A, O’Sullivan M, Peaceman A, Hankins G, Langer O, Caritis S, Roberts J. Magnesium sulfate for the prevention of cerebral palsy. New England Journal of Medicine 2008;359:895‐905.